Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925959 · ClinicalTrials.gov registry record · NA
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
A NA study of Abdominal Wall Hernia, sponsored by Benjamin T. Miller.
- Recruiting
- Registry status
- NA
- Development phase
- 258
- Enrollment target
- 2
- Study locations
NCT05925959: Recruiting NA study of Abdominal Wall Hernia, sponsored by Benjamin T. Miller.
NCT05925959 is a NA study of Abdominal Wall Hernia that is actively recruiting participants, run by Benjamin T. Miller. The registered enrollment target is 258 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05925959, a NA study of Abdominal Wall Hernia, is actively recruiting participants, sponsored by Benjamin T. Miller.
- RECRUITING
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this randomized controlled trial is to compare preoperative intensive weight management to upfront surgery in obese patients undergoing complex abdominal wall reconstruction. The main question is will abdominal wall specific quality of life (using the HerQLes survey) for the group undergoing upfront surgery be non-inferior compared to the group in the weight management program.
Primary Outcome
This will be measured at 1 year using the HerQLes survey which is scored from 0-100 with higher scores indicating better quality of life.
Conditions Studied
Interventions
- OTHER Preoperative Weight Management Program
Study Locations (2)
Illinois
- Northwestern University - Chicago
Ohio
- Cleveland Clinic Main Campus - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT05925959 shows while recruiting
NCT05925959 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Abdominal Wall Hernia appearing as the primary indexed condition, and to 1 intervention - of which Preoperative Weight Management Program is the first listed.
NCT05925959 reports a single indexed study location in Illinois, Ohio.
Frequently Asked Questions
What is clinical trial NCT05925959 about?
NCT05925959 is a clinical study titled "Preoperative Weight Loss for Open Abdominal Wall Reconstruction". The goal of this randomized controlled trial is to compare preoperative intensive weight management to upfront surgery in obese patients undergoing complex abdominal wall reconstruction. The main question is will abdominal wall specific quality of life (using the HerQLes survey) for the group underg...
What is the current status of trial NCT05925959?
This trial is currently recruiting. It is a NA study. The enrollment target is 258 participants. The study started on 2023-06-19. Estimated completion is 2027-06-01.
What conditions does trial NCT05925959 study?
This clinical trial studies the following conditions: Abdominal Wall Hernia.
What interventions are being tested in trial NCT05925959?
The interventions under investigation include: Preoperative Weight Management Program (OTHER).
Who is sponsoring clinical trial NCT05925959?
This trial is sponsored by Benjamin T. Miller, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05925959 being conducted?
This trial has 2 study locations across Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Wall Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05925959's enrollment target sits among peer trials
258 402nd of 2000 higher than 1,598 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI